PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Bachem and Eli Lilly link up to advance oligonucleotide products

The agreement will see the two companies expand current oligonucleotide technologies. Bachem – the Swiss pharmaceutical company – has partnered with Eli Lilly, to...
Continue Reading →
News

Vertex trial for hypoglycaemia therapy shows early promise

New data now reveals significant increases in the blood glucose time-in-range compared to baseline, following VX-880 dosage. Vertex Pharmaceuticals has provided a...
Continue Reading →
News

Daiichi Sankyo and AstraZeneca’s Enhertu delivers promising trial results

Enhertu reduced the risk of disease progression or death compared to chemotherapy in certain patients with metastatic breast cancer. Daiichi Sankyo and AstraZenec...
Continue Reading →
News

Cambridge Pharma promises to boost drug development

A new facility opens in Cambridge Research Park offering pharmaceutical development services. Pharma and medical device manufacturer, SMC, has announced the openi...
Continue Reading →
News

FDA approves GSK measles vax

The U.S. FDA has approved Priorix, GlaxoSmithKline’s vaccine for measles, mumps and rubella (MMR) for use in patients aged 12 months and older. While me...
Continue Reading →
News

Novartis confirms cyberattack, says no sensitive data stolen

Novartis confirmed to Swiss media sources that while the drugmaker was a victim of a cyberattack, no sensitive data was compromised. The pharma company had data s...
Continue Reading →
News

NRG receives £2.68m funding boost for neurodegenerative disorders

NRG Therapeutics announces multi-million Innovate UK Award to develop treatments for Parkinson’s and motor neurone disease Neuroscience company NRG Therapeutics h...
Continue Reading →
News

Thousands to potentially benefit from Roche treatment for sight loss

Faricimab is administered as an eye injection with an interval of up to 16 weeks The National Institute for Health and Care Excellence (NICE) has recommended Roch...
Continue Reading →
News

Memo Therapeutics initiates pioneering BK virus therapy trial

Antibody addresses a high unmet medical needs in the rapidly growing kidney transplant market Memo Therapeutics has announced the initiation of a clinical study t...
Continue Reading →
News

NICE approves Merck’s Keytruda for adult patients with rare triple negative breast cancer

The injection is given in combination with chemotherapy and administered once every three weeks Merck & Co – known as MSD outside the US and Canada – has rece...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026